For research teamsHelp me find a study
Back to all studies
Not recruitingEUCTR 2018-000821-29

A Phase 4, Multicenter, 2-part Study Composed of a 1-Year Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a 1-Year Open-lab...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

ADHD, Children, Adolescents, Under 18Drug

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What the source confirms

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

What should you check before joining?

Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View the historical EU CTR record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
288
Sponsor
Takeda Development Center Americas, Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Belgium, Germany, Netherlands, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2018-000821-29
Official title
A Phase 4, Multicenter, 2-part Study Composed of a 1-Year Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a 1-Year Open-lab...

Check recruitment and locations

EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

View the historical EU CTR record (opens in a new tab)View the current CTIS record (opens in a new tab)
Current CTIS country statuses
Historical EU CTR country statuses

UK records in EU CTR have not been updated since 1 January 2021. An old ongoing status does not confirm current recruitment.

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Belgium · 2 sites
  • UZ Leuven — Neurology
    Leuven
    Country status: Not recruiting
  • CHU UCL Namur — Pediatry
    Namur
    Country status: Not recruiting
Germany · 4 sites
  • Medical Center - University Of Freiburg — Kinder und Jugendpsychiatrie
    Freiburg Im Breisgau
    Country status: Not recruiting
  • University Hospital Cologne AöR — Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters
    Köln
    Country status: Not recruiting
  • Rheinhessen-Fachklinik Mainz — Kinder- und Jugendpsychiatrie, -psychotherapie
    Mainz
    Country status: Not recruiting
  • Central Institute Of Mental Health — Klinik f. Psychiatrie und Psychotherapie
    Mannheim
    Country status: Not recruiting
Netherlands · 1 site
  • EB FlevoResearch B.V. — NA
    Almere
    Country status: Not recruiting
Spain · 5 sites
  • Clínica Doctor Quintero — Psyquiatry
    Madrid
    Country status: Not recruiting
  • Hospital Universitario Fundacion Alcorcon — Psyquiatry
    Madrid
    Country status: Not recruiting
  • Hospital Universitario Infanta Leonor — Psyquiatry
    Madrid
    Country status: Not recruiting
  • University Clinic Of Navarra — Psyquiatry
    Pamplona
    Country status: Not recruiting
  • Parc Tauli Hospital Universitari — Psyquiatry
    Sabadell
    Country status: Not recruiting
Sweden · 1 site
  • Vaestra Goetalandsregionen — Dep of Pediatrics
    Goteborg
    Country status: Not recruiting

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: EUCTR 2018-000821-29. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What does the official source confirm?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Is this study recruiting?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

How can I check the participation requirements?

Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Drug study icon
Not recruitingEUCTR 2010-018579-12

A Phase 3, Randomised, Double-blind, Multicentre, Parallel-group, Placebo- and Active-reference, Dose-optimisation Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Drug study icon
Not recruitingEUCTR 2011-005452-34

A Phase 4, Randomised, Double-blind, Multicenter, Parallel-group, Active-controlled, Forced-dose Titration, Safety and Efficacy Study of SPD489 Compared with OROS-MPH with a Placebo Referance Arm, ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.